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Available online 26 April 2007Edited by Maurice MontalAbstract The membrane leakage caused by the cell penetrating
peptide Tp10, a variant of transportan, was studied in large uni-
lamellar vesicles with the entrapped ﬂuorophore calcein. The
vesicles were composed of zwitterionic 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine. A signiﬁcant decrease in membrane
leakage was found when the 55 kDa streptavidin protein was
attached to Tp10. When a 5.4 kDa peptide nucleic acid molecule
was attached, the membrane leakage was comparable to that
caused by Tp10 alone. The results suggest that direct membrane
eﬀects may cause membrane translocation of Tp10 alone and of
smaller complexes, whereas these eﬀects do not contribute for
larger cargoes.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cell-penetrating peptides (CPPs) have the ability to translo-
cate through cell membranes with high eﬃciency [1–3]. When
they are covalently linked to a larger cargo, such as polypep-
tides, oligonucleotides or proteins, they still retain their trans-
location properties [4]. These short, synthetic peptide based
vectors are considered as biocompatible and economical candi-
dates for delivery of hydrophilic drugs (especially in connec-
tion with gene therapy) [1,2,5,6]. Transportan is a chimeric
CPP constructed from the (1–12) amino acid residues from
the N-terminal part of the neuropeptide galanin linked with
a lysine residue to the full length wasp venom mastoparan
[7]. Transportan 10 (Tp10) was developed as an analog to
transportan by deleting the ﬁrst six N-terminal amino acids,
in order to reduce toxicity [8]. Tp10 has the sequence
AGYLLGKINLKALAALAKKIL [8]. Tp10 and transportan
have remarkably good translocation capabilities and has suc-
cessfully been used as delivery vectors for peptide nucleic acidAbbreviations: CPP, cell-penetrating peptide; Tp10, transportan 10;
PNA, peptide nucleic acid; LUVs, large unilamellar vesicles; POPC,
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPG, 1-palmi-
toyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; bt, biotin labeled
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shown to induce membrane leakage in model systems [13]. Pre-
vious studies have also shown that Tp10 is toxic to cancer cells
(assayed as leakage of lactate dehydrogenase) and that the
peptide induces hemolysis [14].
The CPPs are a variable group of peptides, and their mech-
anisms of action have been under intense debate. Only rela-
tively recently [15] some consensus has appeared: Cargo
delivery is mostly endocytosis-driven and very likely dependent
on endosomal escape. Direct membrane interaction mecha-
nisms seem to operate in parallel in some cases, as has been
suggested for Tp10 [16]. Such interactions have been mainly
associated with highly eﬃcient CPPs, which however also dis-
play cytotoxic activities [14]. The modifying eﬀects of diﬀerent
cargoes on the uptake mechanisms have also been reported
[17,18].
Whereas it seems clear that cargoes aﬀect the CPP uptake
mechanisms in cells, less work has been done on how attach-
ment of cargo may aﬀect the membrane perturbations induced
by CPPs. Of particular interest is then the group of highly eﬃ-
cient CPPs which are considered to be somewhat cytotoxic.
The aim of the present work is to evaluate the membrane inter-
actions of Tp10 carrying diﬀerent biologically relevant cargoes.
Tp10 and transportan are structurally similar to active antimi-
crobial peptides, since they contain the mastoparan sequence
[19,20]. In this respect similar to the antimicrobial peptides
magainin and buforin, Tp10 may also have more than one
uptake mechanism, and the relative importance of these mech-
anisms may depend on the cargo [17,18].
We have compared the membrane perturbation eﬀects of
Tp10bt alone and in complex with a large and hydrophilic car-
go such as streptavidin (55 kDa), or a smaller and hydropho-
bic cargo such as 18 bases long PNA (5.4 kDa). Streptavidin
[21,22] was coupled to Tp10 via a biotin molecule attached
to the Lys 7 of Tp10. The PNA was covalently attached to
Tp10 by a disulﬁde bond. The membrane perturbation by
the diﬀerent constructs was studied by calcein leakage experi-
ments in large unilamellar vesicles (LUVs) composed of phos-
pholipids. Our hypothesis was that membrane perturbation
(manifested as calcein leakage in a vesicle model system)
should be strongly connected to CPP activity due to direct
membrane interactions, as well as to the endosomal escape
of eﬃcient CPPs.
Phospholipid vesicles are artiﬁcial membrane systems which
are suitable mimics of the properties of biological membranes.
With phospholipid vesicles it is possible to manipulate the var-
ious parameters of the membrane system such as size orblished by Elsevier B.V. All rights reserved.
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(POPC) was used to create neutral vesicles, whereas POPC:-
POPG mixtures were used in order to create vesicles with net
negative surface charge. The membrane perturbing eﬀect of
Tp10bt and transportan on neutral vesicles was compared to
the eﬀect that they had on vesicles including 25% negatively
charged phospholipids. We also compared the membrane leak-
age caused by transportan, Tp10 and mastoparan, respec-
tively.2. Materials and methods
2.1. Materials
Transportan was purchased from Neosystems (Strasbourg, France).
Biotin labeled Tp10 was synthesized at the Department of Neurochem-
istry, Stockholm University. Mastoparan from the venom of wasp
(zoological name) was obtained from NeoMPS (Strasbourg, France).
The identity and purity were controlled by amino acid, mass spectro-
metric and HPLC analysis. 1-Palmitoyl-2-oleoyl-phosphocholine
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glyc-
erol)] (POPG) were purchased from Avanti Polar Lipids (Alabaster,
Alabama), of the best quality, and were used without further puriﬁca-
tion. Calcein, a ﬂuorescein derivative (C30H26N2O13, Mw = 622.5 g/
mole), was purchased from Sigma-Aldrich (Stockholm, Sweden).
Streptavidin was obtained from MP Biomedicals (Illkirch, France),
and was used as purchased. The Tp10-PNA construct was prepared
as previously described [23]. In brief, the PNA was attached with a
disulphide bridge to the e-amino group of Lys 7. The single stranded
PNA used was an 18 bases long sequence (underlined), C- and N-ter-
minally ﬂanked with two lysines (K) on either side: (Cys)-
KKCCTCTTACCTCAGTTACAKK (Mw = 5380.4 Da).2.2. Determination of peptide concentrations
The peptide concentrations in the stock solutions were determined
by light absorption on a Cary 4 spectrophotometer using cuvettes with
a 1 cm light path. All the spectra were baseline corrected. A molar
absorptivity of 5600 M1 cm1 and 1280 M1 cm1, at 280 nm, for
tryptophan and tyrosine, respectively, were applied in the calculations.
Mastoparan does not include any tryptophans or tyrosines and its con-
centration was therefore determined by amino acid analysis at Protein
Analysis Center, Department of Medical Biochemistry and Biophysics,
Karolinska Institute, Stockholm.1002.3. Determination of PNA concentration
PNA concentration in the stock solution was determined by light
absorption on a Cary 4 spectrophotometer using cuvettes with 1 cm
light path. The spectra were baseline corrected. A molar absorptivity
of 164.3 mM1 cm1 at 260 nm was used for this PNA.0
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Large unilamellar vesicles were prepared by initially dissolving the
phospholipids (POPC or POPC:POPG 3:1 mixtures, respectively) at
the desired concentration in methanol, to ensure complete mixing of
the components, and then removing the solvent by placing the sample
under a stream of nitrogen or argon to create a thin lipid ﬁlm. Further
solvent was removed by vacuum drying for 3 h. The dried lipids were
then dispersed in 50 mM potassium phosphate buﬀer (pH 7.0). The
solution was vortexed to form large multilamellar vesicles (LMVs).
The dispersion was run through a repeated freeze–thaw cycle 10 times,
which resulted in decreased lamellarity, and then extruded through two
polycarbonate ﬁlters (0.1 lm pore size) 20 times in an Avanti manual
extruder. This process gave unilamellar vesicles with a size of 100 nm.Fig. 1. Calcein leakage from LUVs induced by Tp10bt (black squares),
Tp10bt pre-incubated with two times excess of streptavidin (black
circles) and Tp10bt pre-incubated with four times excess of streptavidin
(open circles) respectively. Increasing concentrations of the peptide
and peptide + streptavidin solutions were added to LUVs composed of
100 lM POPC with 70 mM calcein entrapped. The % calcein release
after 5 min at room temperature and pH 7.0 was plotted as a function
of peptide concentration.2.5. Fluorescence spectroscopy
Fluorescence was measured on a Perkin–Elmer LS 50B luminescence
spectrometer with FLWINLAB software. All measurements were
made in 4 ml plastic cuvettes (1 · 1 cm) at an ambient temperature
of approximately 20 C. The ﬂuorescence intensity of calcein was mea-
sured at 512 nm (excited at 490 nm). Scans were recorded with 2.5 nm
excitation and emission bandwidths and a scan speed of 800 nm/min.2.6. Peptide-induced calcein release
LUVs with entrapped calcein were prepared by hydrating a lipid ﬁlm
of desired composition with 70 mM calcein present in the buﬀer (the
ﬁnal pH was adjusted to 7.0 by addition of NaOH from a 1 M stock
solution). Calcein gives low ﬂuorescence intensity at 70 mM because
of self-quenching and the intensity increases considerably upon dilu-
tion. Free calcein was separated from the LUVs on a Sephadex-G25
column purchased from Amersham Biosciences (Uppsala, Sweden).
Increasing concentration of peptides was added to LUVs composed
of 100 lM phospholipids. After 5 min incubation, release of calcein
from the LUVs was monitored by an increase in the ﬂuorescence inten-
sity at 512 nm.
The maximum ﬂuorescence intensity corresponding to 100% leakage
was determined by lysing the vesicles with 10% triton X-100. The %
leakage was then calculated according to the following equation:
%Leakage ¼ 100fðF  F 0Þ=ðF max  F 0Þg
where F0 represents the ﬂuorescence intensity of the intact vesicles, F
and Fmax, the intensity before and after the addition of the detergent,
respectively.3. Results
3.1. Peptide-induced calcein release from LUVs
The membrane perturbing eﬀect of Tp10bt was investigated
through calcein-release experiments in LUVs. Fig. 1 depicts
the % leakage induced by Tp10bt with neutral POPC LUVs,
after 5 min of incubation, at room temperature. The results
show that Tp10bt causes membrane leakage at quite low con-
centrations.
3.2. Membrane perturbations with streptavidin as cargo
Fig. 1 also depicts the calcein leakage eﬀect of Tp10bt when
attached to streptavidin (55 kDa). Streptavidin can bind up to
four molecules of Tp10bt. Two and four times excess concen-
tration of streptavidin to Tp10bt was used, respectively. For
both cases a similar and drastic decrease in the membrane leak-
age could be seen compared to Tp10bt alone. Streptavidin was
used in excess to ensure complete utilization of Tp10bt in com-
plex formation. This complex was found much less membrane
perturbing than Tp10bt alone. The leakage was reduced almost
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used (Fig. 1).
3.3. Membrane perturbations eﬀects with PNA
Peptide nucleic acid (PNA, 5.4 kDa) was covalently coupled
to Tp10. Fig. 2 shows the membrane leakage caused by Tp10bt,
and the Tp10-PNA construct. In this case the added cargo had
only a small eﬀect on the membrane perturbation and leakage
caused by Tp10.
3.4. Comparison of activities of peptides
The membrane perturbation eﬀect of Tp10bt was compared
with that of its parent peptide transportan and with the potent
antimicrobial peptide mastoparan which has the same
sequence as the C-terminus of Tp10 and transportan. The re-
sults in Fig. 3 show that mastoparan was most potent and
caused severe membrane leakage at very low concentrations.
Transportan was less membrane perturbing than mastoparan,
but Tp10bt was found to be far less membrane disturbing than
both the other peptides. The kinetics of calcein release from
100 lM LUVs was studied for mastoparan, transportan and
Tp10, respectively. For the three peptides the release appeared
to be biphasic with a rapid initial phase followed by a much
slower process. When peptide concentrations were adjusted0
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Fig. 2. Calcein leakage from POPC LUVs caused by addition of
Tp10bt (black squares) and Tp10-PNA (grey triangles) as a function of
peptide concentration.
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Fig. 3. Calcein leakage caused by the three diﬀerent peptides;
mastoparan (grey diamonds), transportan (black circles) and Tp10bt
(black squares). LUVs consisting of 100 lM POPC with 70 mM
calcein enclosed were titrated with the diﬀerent peptides, respectively.
The experiments were done at room temperature at pH 7.0 with an
incubation time of 5 min.
Cpeptide (µM)
Fig. 4. Comparison between the calcein leakage caused by Tp10bt and
transportan from LUVs consisting of POPC or POPC:POPG 3:1
mixtures, respectively. (a) Calcein release when Tp10btwas added to
100 lM POPC vesicles (black squares) and 100 lM POPC:POPG 3:1
vesicles (grey diamonds), respectively. (b) Calcein release when
transportan was added to 25 lM POPC vesicles (black circles) and
25 lM POPC:POPG 3:1 vesicles (grey triangles), respectively.to correspond to a similar amount of leakage (60% after
20 min), the kinetics for the diﬀerent peptides turned out to
be very similar (data not shown).
3.5. Membrane perturbing eﬀects on vesicles including negatively
charged phospholipids
The membrane perturbing eﬀect of Tp10bt (Fig. 4a) and
transportan (Fig. 4b) on neutral vesicles was compared to
the eﬀect that they had on vesicles including 25% negatively
charged phospholipids. The negatively charged vesicles con-
tained POPC:POPG mixtures (molar ratio 3:1). Both peptides
had a much stronger eﬀect on the neutral vesicles than on the
charged vesicles at the lowest peptide concentrations.4. Discussion
Tp10 structurally resembles antimicrobial, pore forming
peptides. It interacts with the membrane in a partly hydropho-
bic manner and exhibits strong eﬀects on the membrane integ-
rity. These observations provide a link between observed
translocation across cell membranes and the induction of leak-
age in the LUV model systems, similar to what has been re-
ported for magainin and buforin [17,18].
We have now studied the extent of membrane leakage when
diﬀerent cargo molecules are attached to Tp10. To use strepta-
vidin as a large and hydrophilic cargo, Tp10 was biotinylated
at position Lys 7. Streptavidin has a high aﬃnity for biotin. It
2392 E. Ba´ra´ny-Wallje et al. / FEBS Letters 581 (2007) 2389–2393has been shown previously that Tp10bt is able translocate
through membranes when bound to streptavidin [24]. The
large reduction of leakage for the Tp10-streptavidin complex
suggests that the use of a suitable cargo can reduce the toxicity
of Tp10 to some extent.
In other experiments PNA was used as a cargo. The Tp10-
PNA construct, which is relatively hydrophobic and with addi-
tional positive charges, turned out to be only slightly less
membrane perturbing than Tp10bt alone. PNA are useful tools
for antisense gene therapy, but they suﬀer from poor uptake
since they are membrane impermeable [25]. Tp10-mediated
uptake should be quite eﬃcient, given that the cytotoxicity
can be tolerated. In this study the PNA was conjugated with
the CPP by a disulphide bond, which has proven to be an eﬃ-
cient way to do the linkage [26]. Inside the cell, this bond may
be reduced by cytosolic components and free PNA can move
to its designated target [27].
Tp10 and mastoparan are both fragments of transportan.
Mastoparan, a potent wasp venom peptide, caused maximal
membrane leakage. It is suggested to have a transmembrane
orientation, favoring pore formation [28–31]. A pore may be
deﬁned either as a well deﬁned structure, e.g. composed of a
number of helices in parallel alignment, or as a less well-deﬁned
peptide-induced structural defect in the membrane through
which ions or molecules can pass. The latter deﬁnition may
be most suitable for CPPs like Tp10 and transportan.
The membrane perturbing eﬀect of Tp10 as well as transpor-
tan is signiﬁcantly stronger on neutral vesicles consisting of
POPC than on negatively charged vesicles consisting of POPC:-
POPG mixtures (see Fig. 4). The diﬀerences observed in the
present study are surprisingly big at the lowest measured pep-
tide concentrations. Although these eﬀects may partly be due
to speciﬁc interactions between the peptides and the phospho-
lipid headgroups, they also suggest a competition between elec-
trostatic forces and hydrophobic forces [32]. For a bilayer
consisting of zwitterionic phospholipids these peptides could
possibly be inserted more deeply into the hydrophobic part of
the bilayer causing leakage, whereas for negatively charged lip-
ids the electrostatic attraction could keep the peptide in the
headgroup region. Similar observations have previously been
reported for the bee venom melittin [28,29,31,33].
The varying induction of membrane leakage by Tp10 with
and without cargoes indicates that the mechanism by which
this class of CPPs translocates through the membrane may
depend on whether a large cargo is attached to the peptide
or not. In the absence of large hydrophilic cargoes the peptide
may induce membrane disturbances that allows for direct
translocation of peptide into the cell. In the presence of a large
hydrophilic cargo, such as streptavidin, the membrane distur-
bance is small and endocytosis is probably the only transloca-
tion mechanism [24,34–36]. For another class of CPPs (e.g.
penetratin) that are generally less toxic, there is no evidence
of membrane leakage in model systems [37].
The present results suggest a further step forward in under-
standing the mechanisms of CPPs. Given the right conditions
CPPs use endocytosis (including endosomal escape) when
entering cells, without or with cargo. Certain peptides like
transportan or Tp10 which cause leakage in membrane model
systems, can in addition enter cells via direct membrane inter-
actions (transient pore formation). Our present results suggest
that this additional pathway is strongly dependent on cargo.
The non-endocytotic pathway may be inhibited by largehydrophilic cargoes, but allowed with smaller hydrophobic
or positively charged cargoes.
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